Literature DB >> 29721019

Establishing Differences in Thermographic Patterns between the Various Complications in Diabetic Foot Disease.

Alfred Gatt1, Owen Falzon2, Kevin Cassar3, Christian Ellul1, Kenneth P Camilleri2,4, Jean Gauci2, Stephen Mizzi1, Anabelle Mizzi1, Cassandra Sturgeon3, Liberato Camilleri5, Nachiappan Chockalingam6, Cynthia Formosa1.   

Abstract

AIM: To evaluate the potential of thermography as an assessment tool for the detection of foot complications by understanding the variations in temperature that occur in type 2 diabetes mellitus (DM).
METHODS: Participants were categorized according to a medical examination, ankle brachial index, doppler waveform analysis, and 10-gram monofilament testing into five groups: healthy adult, DM with no complications, DM with peripheral neuropathy, DM with neuroischaemia, and DM with peripheral arterial disease (PAD) groups. Thermographic imaging of the toes and forefeet was performed.
RESULTS: 43 neuroischaemic feet, 41 neuropathic feet, 58 PAD feet, 21 DM feet without complications, and 126 healthy feet were analyzed. The temperatures of the feet and toes were significantly higher in the complications group when compared to the healthy adult and DM healthy groups. The higher the temperatures of the foot in DM, the higher the probability that it is affected by neuropathy, neuroischaemia, or PAD.
CONCLUSIONS: Significant differences in mean temperatures exist between participants who were healthy and those with DM with no known complications when compared to participants with neuroischaemia, neuropathy, or PAD. As foot temperature rises, so does the probability of the presence of complications of neuropathy, neuroischaemia, or peripheral arterial disease.

Entities:  

Year:  2018        PMID: 29721019      PMCID: PMC5867599          DOI: 10.1155/2018/9808295

Source DB:  PubMed          Journal:  Int J Endocrinol        ISSN: 1687-8337            Impact factor:   3.257


1. Introduction

The diabetic foot is characterized by the presence of various complications that typically tend to develop as a result of poor glycaemic control. The main complications include neuropathy, peripheral arterial disease (PAD), and neuroischaemia, amongst others. These complications are amongst the most serious and costly as they often lead to amputation. In many cases, development of diabetic foot complications can be avoided or substantially delayed with timely assessment, diagnosis, and treatment provided at an early stage of the disease. Prophylactic foot care has been shown to decrease patient morbidity [1]. Common diabetic foot complications such as ischaemia and neuropathy have an effect on the temperature of the foot [2]. It is postulated that changes in temperature of the foot may be indicative of the presence of such complications. Thermography or medical infrared imaging may be used to detect temperature changes. This technique is deemed safe since it is noncontact, noninvasive, and nonirradiant and has been utilized in a number of medical applications including imaging of the breast [3], skin [4] and foot vascular complications, and ulceration in diabetes [5-7]. The current clinical practice of temperature assessment is mainly by manual palpation of foot temperature. However, a gradual increase in foot temperature may be too subtle to be detected only by the hand, making the timely and early detection of underlying pathology difficult. It has been established that increased temperatures in the foot may be present up to a week before a foot ulcer occurs [8], thus making it important for any variations in temperature to be detected promptly. Thermal imaging offers an excellent means of making a quantitative determination of surface temperature and can offer an alternative mode of detection of major foot complications since it has been reported that monitoring of skin temperature reduces the risk of diabetic foot ulceration in high-risk patients [9]. Although Nagase et al. had looked at variations in plantar thermographic patterns in normal controls and nonulcer diabetic patients, it has not been fully elucidated to what extent the individual variations of the plantar thermographic patterns show different trends between these two cohorts [10]. Presently, little is known about the range of abnormal thermoregulation in those patients with diabetes presenting both for screening and management [8]. The aim of this study was to evaluate the potential of thermography as an assessment tool for the detection of type 2 diabetic foot disease by assessing the variations in temperature that occur in the diabetic foot before ulceration appears. Objectives were to find a possible correlation between temperature readings of the plantar foot and toes in diabetic foot complications to reduce the risk of foot ulceration by early detection of pathologies.

2. Method

This study employed medical infrared imaging to visualize the temperature distribution of the feet of participants living with DM with or without complications and healthy controls. Following ethical approval from the University Ethics Committee, initially, healthy adult participants were recruited, medically examined, and imaged as reported elsewhere [11] whilst participants with type 2 diabetes mellitus were recruited from the patient list of a vascular surgeon. All participants underwent a thorough clinical examination that included validated tests for neuropathy [12] and peripheral arterial disease [13]. Participants with DM were categorized into 4 groups based on the medical examination and testing: a heathy DM group (i.e., presenting with DM but no significant medical comorbidities and/or complications), a PAD group (presenting with ABPI < 0.6 and monophasic Doppler spectral waveforms at the ankles, but no neuropathy), a neuropathic group (presenting with positive 10-gram monofilament at any one of 10 tested sites and/or reduced vibration perception threshold as measured with a tuning fork and an ABPI between 0.9 and 1.3), and a neuroischaemic group (presenting with ABPI < 0.9 and neuropathy). Participants who presented with active ulceration or other significant comorbidities that could affect the distribution of thermographic patterns, such as rheumatoid arthritis or Raynaud's phenomenon, were excluded. Following a 15-minute acclimatization period, all participants rested in a supine position on a couch in a room which was temperature controlled at 23°C. An ABPI was obtained [14, 15], according to standard clinical practice utilizing a Huntleigh (Cardiff, Wales) Dopplex Assist. A cuff was applied proximal to the ankle, and an 8 Mhz doppler probe was applied at the posterior tibial artery and the dorsalis paedis artery. The probe was held at an angle of 45° against blood flow while the cuff was inflated until the doppler signal was cut off. Then the cuff pressure was slowly released. Once the signal was reobtained, the systolic pressure of the particular artery was noted. This process was repeated for the brachial artery; the cuff was applied above the elbow and the doppler probe was held in order to obtain its systolic pressure. The ABPI was calculated with the higher of the posterior tibial and dorsalis paedis pressures being taken into consideration. Normal ABPI values ranged from 0.9 to 1.3. Spectral Doppler waveform analysis was also employed to classify the recorded waveform as being triphasic, biphasic, or monophasic [16]. A triphasic waveform is indicative of normal arterial perfusion, whilst the other two classifications are indicative of PAD, with the monophasic waveform denoting a more severe form of the condition. Only those participants with monophasic waveforms and an ABPI < 0.6 were included to ensure an unequivocal diagnosis of PAD. Testing for neuropathy involved the use of a 10 g Semmes Weinstein monofilament administered at 10 sites on each foot. In this validated method, exactly 10 g of force was applied before the monofilament bent, thus ensuring that exactly the same amount of force is applied. Neuropathy was diagnosed if at least one site was not felt by the participant. All the above measurements were carried out by the same experienced clinician in order to ensure consistency.

3. Image Acquisition, Segmentation, Data Extraction, and Analysis

A FLIR SC7200 infrared camera with a spatial resolution of 320 × 256 pixels and a temperature resolution of 20 mK was used for the acquisition of thermal images. The protocol for obtaining thermal images followed the recommendations of the American Academy of Thermology [17]. The camera was placed on a tripod 1.5 m from the subject and perpendicular to the body part that was being photographed [11]. Images of the plantar aspect of the feet were recorded for later analysis. Thermal images obtained of the feet were divided into regions so that temperature data could be extracted (Figures 1(a) and 1(b)) [11].
Figure 1

(a) Diagram showing the foot regions considered for temperature extraction. (b) An actual thermal image and the corresponding regions of interest. The temperatures from the toe regions and forefoot regions were considered for further analysis.

4. Results

Thermographic images from 43 neuroischaemic limbs (from 30 subjects), 41 neuropathic limbs (from 32 subjects), 58 PAD limbs (from 42 subjects), 21 DM healthy limbs (15 subjects,), and 126 healthy limbs (from 63 subjects) were analyzed. When analyzing the mean temperature data in all 5 toes and 3 plantar regions of the forefoot (medial, central, and lateral regions) (Figures 2 and 3), there are significant differences in mean temperatures between the five groups of patients, as demonstrated by the Tukey test (Table 1). This test clusters these five groups into two groups where the mean temperatures of diabetic participants with peripheral arterial disease, diabetes patients with neuropathy, and diabetes patients with neuroischaemia are significantly higher than the mean temperatures of healthy adults and diabetes patients with no known complication. Thus, for further statistical comparison, these five categories were divided into a “healthy group” (comprised of healthy adults and DM participants with no known complications) and a “complications group” (comprised of neuropathic, neuroischaemic, and PAD participants).
Figure 2

Toe temperature distribution.

Figure 3

Forefoot temperature distribution.

Table 1

Tukey test to compare mean temperatures between the two groups.

Sample sizeMeanStd. deviation p value
Toe 1Neuropathic, neuroischaemic, and PAD12127.832.6370.000
Healthy and DM healthy12325.523.473
Toe 2Neuropathic, neuroischaemic, and PAD12827.382.8990.000
Healthy and DM healthy12225.123.452
Toe 3Neuropathic, neuroischaemic, and PAD13127.332.8860.000
Healthy and DM healthy12325.193.476

Toe 4Neuropathic, neuroischaemic, and PAD12527.272.9260.000
Healthy and DM healthy12325.213.317
Toe 5Neuropathic, neuroischaemic, and PAD12527.292.8520.000
Healthy and DM healthy12325.383.238
Medial forefootNeuropathic, neuroischaemic, and PAD13528.672.4540.000
Healthy and DM healthy12326.882.874

Central forefootNeuropathic, neuroischaemic, and PAD13428.352.4740.000
Healthy and DM healthy12326.682.835
Lateral forefootNeuropathic, neuroischaemic, and PAD13028.582.3740.000
Healthy and DM healthy12326.802.861

5. Logistic Regression Analysis

In the first logistic regression model fit, we relate the health status (neuropathic, neuroischaemic, or PAD; healthy or DM healthy) to two predictors, which include toe temperature and toe location. As indicated in Table 2, a binomial distribution is assumed since the dependent variable has two categories, while a logit link function is used since this is the canonical link for the binomial distribution.
Table 2

Likelihood ratio tests (model 1).

Likelihood ratio tests
EffectModel fitting criteriaLikelihood ratio tests
−2 log likelihoodChi-squaredf p value
Intercept1495.6590.0000.
Temperature1634.676139.0210.000
Toe location1496.7141.05540.901
Toe location was not found to be a significant predictor since the p value (0.901) exceeds the 0.05 level of significance. A backward procedure was used to fit the parsimonious model, which identified temperature as a sole significant predictor. As shown in Table 3, the regression coefficient of temperature (0.220) is positive indicating that the toe temperature of neuropathic, neuroischaemic, or PAD participants is expected to be higher than that of healthy or DM healthy patients. The odds ratio indicates that the odds that the participant has neuropathy, neuroischaemia, or PAD rather than being healthy increases by 24.7% for every 1°C increase in toe temperature. This odds ratio ranges from 19.8% to 29.7% assuming a 95% confidence level. The logistic regression model that yields the probability that a patient has neuropathy, neuroischaemia, or PAD given the toe temperature is given by where p is the probability that the participant has neuropathy, neuroischaemia, or PAD and 1 − p is the probability that the patient is healthy. The probability curves displayed in Figure 4 clearly show that the likelihood of neuropathy, neuroischaemia, or PAD increases as the toe temperature increases.
Table 3

Parameter estimates of the logistic regression model for toe temperatures.

EffectBStd. errorWald p valueOdds ratio95% CI for odds ratio
Lower boundUpper bound
Intercept−5.7860.534117.3630.000
Temperature0.2200.020119.6930.0001.2471.1981.297
Figure 4

Logistical regression curves of toe temperatures.

In the second logistic regression model fit, we relate the health status (neuropathic, neuroischaemic, or PAD; healthy or DM healthy) to two predictors, which include temperature and forefoot location, whether medial, central, or lateral. A binomial distribution and a logit link function are again assumed. Plantar location was not found to be a significant predictor since the p value (0.912) exceeds the 0.05 level of significance. A backward procedure was used to fit the parsimonious model, which identified temperature as a sole significant predictor (Table 4).
Table 4

Likelihood ratio tests (model 2).

Likelihood ratio tests
EffectModel fitting criteriaLikelihood ratio tests
−2 log likelihoodChi-squaredf p value
Intercept924.0560.0000.
Temperature1004.52080.46410.000
Plantar forefoot location924.2400.18420.912
The results in Table 5 indicate that the regression coefficient for the plantar forefoot temperature (0.254) is positive indicating that the plantar forefoot temperature of neuropathic, neuroischaemic, or PAD patients is expected to be higher than that of healthy or DM healthy patients. The odds ratio indicates that the odds that the participant has neuropathy, neuroischaemia, or PAD rather than being healthy increases by 28.9% for every 1°C increase in plantar temperature. This odds ratio ranges from 19.8% to 29.7% assuming a 95% confidence level. The logistic regression model that yields the probability that a patient has neuropathy, neuroischaemia, or PAD given the plantar temperature is given by where p is the probability that the patient has neuropathy, neuroischaemia, or PAD and 1 − p is the probability that the patient is healthy. The probability curves displayed in Figure 5 clearly show that the likelihood of neuropathy, neuroischaemia, or PAD increases as the plantar forefoot temperature increases.
Table 5

Parameter estimates of the logistic regression model for forefoot temperatures.

EffectBStd. errorWald p valueOdds ratio95% CI for odds ratio
Lower boundUpper bound
Intercept−6.9490.84667.3950.000
Temperature0.2540.03069.4810.0001.2891.2141.368
Figure 5

Logistical regression curves of forefoot temperatures.

6. Discussion

The results of this thermographic study demonstrate three main inferences: (i) that there are no significant differences in mean temperatures of the toes and forefoot between healthy subjects and patients with diabetes showing no complications; (ii) that there are no significant differences in mean temperatures of these same areas between participants with complications of neuropathy, neuroischaemia, and PAD; (iii) that there are significantly higher mean temperatures in these latter group of subjects when compared to both healthy and DM participants with no complications. This increase in temperature is further confirmed by the logistic regression models of both toe and forefoot areas, which establish temperature as being the sole significant predictor of complications. These models demonstrate that the probability of complications of PAD, neuropathy, and/or neuroischaemia being present increases as the temperature of these regions rises. This study is the first of its kind to report temperature differences between possible categories of complications of DM relative to healthy adults. The authors recommend that these findings and thermographic techniques should be considered for further clinical investigations of the DM patient. These results imply that should a rise in temperature be detected in the diabetic foot, there is a higher likelihood that diabetic foot complications have set in, as further reported by Sun et al. [8] who state that thermographic patterns may change as early as one week prior to ulceration. The findings of the study indicate that an increase in temperature may not necessarily imply impending ulceration, but simply the development of peripheral neuropathy, ischaemia, or both. Further research is warranted to establish whether the inclusion of thermography into screening protocols could help detect the development of diabetic foot complications earlier so that appropriate prompt preventative measures may be taken to avoid unnecessary complications. Whilst neuropathic feet have been previously reported as being warmer than healthy feet, we can now confirm that even neuroischaemic and ischaemic feet exhibit the same trend. This may be due to altered thermoregulatory mechanisms of the feet, which can be affected by both neuropathy and PAD. Local ischaemia may lead to disruption of sympathetically mediated noradrenergic vasoconstriction which leads to increased flow to the cutaneous vessels rather than through the deeper nutritive vessels which in turn leads to higher heat emissivity. Arteriovenous anastamoses (AVA) which are thick-walled, low resistance conduits allow high-flow rates directly from arterioles to venules. AVA are numerous and richly innervated by sympathetic vasoconstrictor nerves. Substantial changes occur in blood flow depending on whether AVAs are closed or open [18]. It is reported that the application of clinical examination or nerve conduction studies alone is not adequate in screening diabetic at-risk feet at early stage [8]; thus, the use of an adjunct method such as thermography may prove useful. Further research into thermographic patterns of patients with diabetes and with active ulcers may help elucidate the natural history of development of ulceration.

7. Conclusions

This study has confirmed that the mean temperatures of the toes and forefeet of the complications group exhibit significantly higher temperatures than those of the healthy group, whilst each group presents with comparable temperatures within themselves. These results indicate that thermography demonstrates potential as a screening or clinical investigation tool, although more research in the area is warranted.
  15 in total

Review 1.  Imaging of skin thermal properties with estimation of ambient radiation temperature.

Authors:  Kimio Otsuka; Shigehisa Okada; Moinuddin Hassan; Tatsuo Togawa
Journal:  IEEE Eng Med Biol Mag       Date:  2002 Nov-Dec

2.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

3.  Relationship of skin temperature to sympathetic dysfunction in diabetic at-risk feet.

Authors:  Pi-Chang Sun; Hong-Da Lin; Shyh-Hua Eric Jao; Yan-Chiou Ku; Rai-Chi Chan; Cheng-Kung Cheng
Journal:  Diabetes Res Clin Pract       Date:  2006-02-17       Impact factor: 5.602

4.  Hidden dangers revealed by misdiagnosed peripheral arterial disease using ABPI measurement.

Authors:  Cynthia Formosa; Kevin Cassar; Alfred Gatt; Anabelle Mizzi; Stephen Mizzi; Kenneth P Camileri; Carl Azzopardi; Clifford DeRaffaele; Owen Falzon; Stefania Cristina; Nachiappan Chockalingam
Journal:  Diabetes Res Clin Pract       Date:  2013-10-09       Impact factor: 5.602

5.  Screening for peripheral vascular disease in patients with type 2 diabetes in Malta in a primary care setting.

Authors:  Cynthia Formosa; Alfred Gatt; Nachiappan Chockalingam
Journal:  Qual Prim Care       Date:  2012

6.  Guidelines for diabetic foot care: recommendations endorsed by the Diabetes Committee of the American Orthopaedic Foot and Ankle Society.

Authors:  Michael S Pinzur; Mark P Slovenkai; Elly Trepman; Naomi N Shields
Journal:  Foot Ankle Int       Date:  2005-01       Impact factor: 2.827

7.  Variations of plantar thermographic patterns in normal controls and non-ulcer diabetic patients: novel classification using angiosome concept.

Authors:  Takashi Nagase; Hiromi Sanada; Kimie Takehara; Makoto Oe; Shinji Iizaka; Yumiko Ohashi; Miho Oba; Takashi Kadowaki; Gojiro Nakagami
Journal:  J Plast Reconstr Aesthet Surg       Date:  2011-01-22       Impact factor: 2.740

8.  Fluctuations in blood flow to acral skin in humans: connection with heart rate and blood pressure variability.

Authors:  K Lossius; M Eriksen; L Walløe
Journal:  J Physiol       Date:  1993-01       Impact factor: 5.182

9.  Skin temperature monitoring reduces the risk for diabetic foot ulceration in high-risk patients.

Authors:  David G Armstrong; Katherine Holtz-Neiderer; Christopher Wendel; M Jane Mohler; Heather R Kimbriel; Lawrence A Lavery
Journal:  Am J Med       Date:  2007-12       Impact factor: 4.965

10.  Comparison of the accuracy of monofilament testing at various points of feet in peripheral diabetic neuropathy screening.

Authors:  Shahram Baraz; Kourosh Zarea; Hajie Bibi Shahbazian; Seyed Mahmoud Latifi
Journal:  J Diabetes Metab Disord       Date:  2014-01-28
View more
  9 in total

1.  Infrared Thermography and Vascular Disorders in Diabetic Feet.

Authors:  Arjaleena Ilo; Pekka Romsi; Jussi Mäkelä
Journal:  J Diabetes Sci Technol       Date:  2019-08-27

Review 2.  A Synoptic Overview of Neurovascular Interactions in the Foot.

Authors:  Gayathri Balasubramanian; Prashanth Vas; Nachiappan Chockalingam; Roozbeh Naemi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-22       Impact factor: 5.555

Review 3.  Telehealth and telemedicine applications for the diabetic foot: A systematic review.

Authors:  Constantijn E V B Hazenberg; Wouter B Aan de Stegge; Sjef G Van Baal; Frans L Moll; Sicco A Bus
Journal:  Diabetes Metab Res Rev       Date:  2019-12-20       Impact factor: 4.876

Review 4.  The Potential Role of Sensors, Wearables and Telehealth in the Remote Management of Diabetes-Related Foot Disease.

Authors:  Jonathan Golledge; Malindu Fernando; Peter Lazzarini; Bijan Najafi; David G Armstrong
Journal:  Sensors (Basel)       Date:  2020-08-13       Impact factor: 3.576

5.  Thermal characteristics of rheumatoid feet in remission: Baseline data.

Authors:  Alfred Gatt; Cecilia Mercieca; Andrew Borg; Andrea Grech; Liberato Camilleri; Corene Gatt; Nachiappan Chockalingam; Cynthia Formosa
Journal:  PLoS One       Date:  2020-12-02       Impact factor: 3.240

6.  Thermal Image-Based Temperament Classification by Genetic Algorithm and Adaboost Classifier.

Authors:  Roshanak Ghods; Vahid Reza Nafisi
Journal:  J Med Signals Sens       Date:  2021-12-28

7.  Holistic multi-class classification & grading of diabetic foot ulcerations from plantar thermal images using deep learning.

Authors:  Shishir Muralidhara; Adriano Lucieri; Andreas Dengel; Sheraz Ahmed
Journal:  Health Inf Sci Syst       Date:  2022-08-26

8.  Infrared thermography for monitoring severity and treatment of diabetic foot infections.

Authors:  Kor H Hutting; Wouter B Aan de Stegge; Rombout R Kruse; Jeff G van Baal; Sicco A Bus; Jaap J van Netten
Journal:  Vasc Biol       Date:  2020-07-21

9.  The Use of Infrared Thermography to Develop and Assess a Wearable Sock and Monitor Foot Temperature in Diabetic Subjects.

Authors:  José Torreblanca González; Beatriz Gómez-Martín; Ascensión Hernández Encinas; Jesús Martín-Vaquero; Araceli Queiruga-Dios; Alfonso Martínez-Nova
Journal:  Sensors (Basel)       Date:  2021-03-05       Impact factor: 3.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.